I rate Perdoceo Education a 'Buy', driven by strong growth in healthcare and nursing degree enrollments amid shifting education trends, especially among Gen Z. PRDO's fundamentals are attractive: rising healthcare enrollments, a healthy balance sheet, 16% YoY revenue growth, and a low P/E ratio suggest undervaluation. While I remain skeptical of for-profit education, the company's focus on care...
Perdoceo Education Corporation is a leading U.S. provider of postsecondary education, offering both online and campus-based programs. Revenue rose 25.7% YoY to $209.6M, driven mainly by the USAHS acquisition, while gross margin fell 5.56pp and net margin declined 3.47pp due to integration and marketing costs. Strong enrollment momentum, strategic investments in generative AI, USAHS acquisition,...
PRDO delivered strong Q2'25 results, beating estimates and raising FY'25 guidance, driven by robust enrollment and exceptional operating leverage. The business exhibits high-quality, capital-light economics, with strong cash generation, minimal CapEx, and superior free cash flow yields. CTU remains the earnings engine, with consistent growth and margin expansion, while AIUS and USAHS require cl...
PRDO's recent earnings beat and raised guidance drove a stock surge, but the valuation now exceeds historical averages, raising caution. Despite strong financials and a capital-light, high-margin model, PRDO is highly dependent on federal funding and faces significant regulatory risk. The for-profit education sector is in structural decline, with negative public perception and tightening regula...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.